Genprex, Inc.
GNPX
$2.83
$0.093.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.15M | 2.18M | 1.43M | 1.50M | 1.57M |
| Depreciation & Amortization | -- | -- | -- | 500.00 | 1.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.35M | 4.68M | 3.97M | 4.34M | 4.32M |
| Operating Income | -3.35M | -4.68M | -3.97M | -4.34M | -4.32M |
| Income Before Tax | -3.80M | -4.67M | -3.96M | -4.61M | -4.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.80M | -4.67M | -3.96M | -4.61M | -4.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.80M | -4.67M | -3.96M | -4.61M | -4.32M |
| EBIT | -3.35M | -4.68M | -3.97M | -4.34M | -4.32M |
| EBITDA | -3.34M | -4.68M | -3.97M | -4.34M | -4.32M |
| EPS Basic | -5.00 | -8.47 | -12.99 | -26.39 | -61.65 |
| Normalized Basic EPS | -3.12 | -5.29 | -8.12 | -15.50 | -38.53 |
| EPS Diluted | -5.00 | -8.47 | -12.99 | -26.39 | -61.65 |
| Normalized Diluted EPS | -3.12 | -5.29 | -8.12 | -15.50 | -38.53 |
| Average Basic Shares Outstanding | 760.50K | 551.90K | 305.30K | 174.60K | 70.00K |
| Average Diluted Shares Outstanding | 760.50K | 551.90K | 305.30K | 174.60K | 70.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |